IO BIOTECH INC's ticker is and the CUSIP is 449778109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,704,549 | +47.7% | 6,173,439 | +104.7% | 0.95% | +134.4% |
| Q2 2023 | $5,895,390 | +4.3% | 3,015,545 | 0.0% | 0.41% | +3.8% |
| Q1 2023 | $5,654,147 | +81418.8% | 3,015,545 | 0.0% | 0.39% | -50.9% |
| Q4 2022 | $6,936 | -99.9% | 3,015,545 | 0.0% | 0.80% | -11.4% |
| Q3 2022 | $8,172,000 | -42.0% | 3,015,545 | 0.0% | 0.90% | -36.2% |
| Q2 2022 | $14,083,000 | -11.9% | 3,015,545 | 0.0% | 1.41% | +28.4% |
| Q1 2022 | $15,982,000 | -17.2% | 3,015,545 | 0.0% | 1.10% | -5.4% |
| Q4 2021 | $19,299,000 | – | 3,015,545 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 3,640,015 | $5,132,421 | 1.57% |
| Vivo Capital, LLC | 6,173,439 | $8,704,549 | 0.95% |
| Stonepine Capital Management, LLC | 1,975,308 | $2,785,184 | 0.92% |
| Novo Holdings A/S | 5,747,067 | $8,103,364 | 0.60% |
| Pivotal bioVenture Partners Investment Advisor LLC | 864,197 | $1,218,518 | 0.49% |
| Logos Global Management LP | 493,827 | $696,296 | 0.09% |
| PFM Health Sciences, LP | 1,353,453 | $1,908,369 | 0.09% |
| ARMISTICE CAPITAL, LLC | 2,148,000 | $3,028,680 | 0.05% |
| Avoro Capital Advisors LLC | 2,055,883 | $2,837,119 | 0.04% |
| Alyeska Investment Group, L.P. | 987,654 | $1,392,592 | 0.01% |